The synthetic pentasaccharide fondaparinux sodium does not interact with oral warfarin.
Faaij
Richard A
RA
Centre for Human Drug Research, Leiden, The Netherlands.
Burggraaf
Jacobus
J
Schoemaker
Rik C
RC
de Greef
Rik
R
Cohen
Adam F
AF
D000284:Administration, Oral; D000328:Adult; D000925:Anticoagulants / Q000097:blood / Q000493:pharmacokinetics*; D018592:Cross-Over Studies; D004311:Double-Blind Method; D004347:Drug Interactions; D005343:Fibrinolytic Agents / Q000097:blood / Q000493:pharmacokinetics*; D000077425:Fondaparinux; D006801:Humans; D007279:Injections, Subcutaneous; D019934:International Normalized Ratio; D008297:Male; D011134:Polysaccharides / Q000097:blood / Q000493:pharmacokinetics*; D014859:Warfarin / Q000097:blood / Q000493:pharmacokinetics*
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D011134:Polysaccharides; D014859:Warfarin; D000077425:Fondaparinux